Literature DB >> 19022293

Performance of a commercial rapid dengue NS1 antigen immunochromatography test with reference to dengue NS1 antigen-capture ELISA.

S Zainah1, A H Abdul Wahab, M Mariam, M K Fauziah, A H Khairul, I Roslina, A Sairulakhma, S S Kadimon, M S Mat Jais, K B Chua.   

Abstract

The performance of a commercial immunochromatography test for rapid detection of dengue NS1 antigen present in serum or plasma of patients was evaluated against a commercial dengue NS1 antigen-capture ELISA. The rapid immunochromatography test gave an overall sensitivity of 90.4% with a specificity of 99.5%. The sensitivity was highest for serum samples from which virus was isolated (96.3%) and lowest for those from which virus was not isolated and RT-PCR was negative (76.4%). The sensitivity was significantly higher for serum samples from patients with acute primary dengue (92.3%) than those from patients with acute secondary dengue (79.1%). The positive predictive value and negative predictive value of this commercial immunochromatography test were 99.6% and 87.9% respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022293     DOI: 10.1016/j.jviromet.2008.10.016

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  21 in total

1.  NS1 detection in addition to reverse transcriptase PCR and transcription-mediated amplification of dengue virus RNA in acutely ill patients.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  J Clin Microbiol       Date:  2009-06       Impact factor: 5.948

2.  NS1-based tests with diagnostic utility for confirming dengue infection: a meta-analysis.

Authors:  Hao Zhang; Wei Li; Junjie Wang; Hongjuan Peng; Xiaoyan Che; Xiaoguang Chen; Yuanping Zhou
Journal:  Int J Infect Dis       Date:  2014-06-28       Impact factor: 3.623

3.  Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India.

Authors:  Ashwini Manoor Anand; Sujatha Sistla; Rahul Dhodapkar; Abdoul Hamide; Niranjan Biswal; Badrinath Srinivasan
Journal:  J Clin Diagn Res       Date:  2016-04-01

4.  Utility of a commercial nonstructural protein 1 antigen capture kit as a dengue virus diagnostic tool.

Authors:  Kovi Bessoff; Elena Phoutrides; Mark Delorey; Luz N Acosta; Elizabeth Hunsperger
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

5.  Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil.

Authors:  Monique da Rocha Queiroz Lima; Rita Maria Ribeiro Nogueira; Hermann Gonçalves Schatzmayr; Flavia Barreto dos Santos
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

6.  A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Toi Pham Van; Sue J Lee; Jeremy Farrar; Bridget Wills; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

Review 7.  Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs?

Authors:  Stuart D Blacksell
Journal:  J Biomed Biotechnol       Date:  2012-05-10

8.  Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection.

Authors:  Lyda Osorio; Meleny Ramirez; Anilza Bonelo; Luis A Villar; Beatriz Parra
Journal:  Virol J       Date:  2010-12-06       Impact factor: 4.099

9.  A new approach to dengue fatal cases diagnosis: NS1 antigen capture in tissues.

Authors:  Monique da Rocha Queiroz Lima; Rita Maria Ribeiro Nogueira; Hermann Gonçalves Schatzmayr; Ana Maria Bispo de Filippis; Daniel Limonta; Flavia Barreto dos Santos
Journal:  PLoS Negl Trop Dis       Date:  2011-05-03

10.  Clinical and laboratory features that discriminate dengue from other febrile illnesses: a diagnostic accuracy study in Rio de Janeiro, Brazil.

Authors:  Regina P Daumas; Sonia R L Passos; Raquel V C Oliveira; Rita M R Nogueira; Ingebourg Georg; Keyla B F Marzochi; Patrícia Brasil
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.